New precision medicine breakthrough will enable 3D printing of medications that are personalized to a specific patient's needs. Early adopters of precision medicine may find value in this new strategy that is focused on medication management.
A new program explores the possibility of treating Alzheimer's disease using precision medicine. What is Accelerating Medicines Partnership Alzheimer's disease program (AMP AD 2.0), and where is research advancing?
Insights into a recently published comprehensive review in Cancer Reports. The review, featuring Icahn School of Medicine at Mount Sinai researchers, discusses the implications of using precision medicine to treat prostate cancer in different populations, particularly African American men.
This research provides new findings on how the scope of genetic testing programs should be expanded, answers what is Watershed.
As COVID-19 research grows, new emphasis on potential individualized treatment options offers promising application of precision medicine The COVID-19 pandemic's unprecedented force of change on traditional medical device and therapeutics development has brought fresh perspectives and new opportunities for precision medicine partnerships. With COVID-19, precision medicine focuses on better understanding of how and why the …
Emerging research shows that time-of-day dependent drug delivery may impact individuals differently based on their chronobiome Recent research into the human chronobiome has shown that the "normal" circadian rhythm can vary significantly in healthy individuals. This means that chronotherapies which are based on an average individual's circadian rhythm may not be as efficacious for everyone. …
Next generation sequencing can play a role by consolidating testing to a single platform, a potential game changer for community and regional hospitals.
Precision medicine is demonstrating its potential value in the face of a second wave of coronavirus outbreak
Stratifying cancer patients switched from adjuvant chemotherapy to targeted treatments during the coronavirus pandemic
Implications of using beneficial cardiovascular precision medicine-based screening approaches to raise awareness in at-risk populations